Skip to content

Battlefield Auricular Acupressure (BAApress) Feasibility Study

Battlefield Auricular Acupressure (BAApress) for Emergency Department Observation Psychiatric Patients With Co-occurring Chronic and Acute Pain Management

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05939388
Enrollment
11
Registered
2023-07-11
Start date
2023-11-14
Completion date
2024-03-01
Last updated
2025-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

auricular acupressure, pain management, acupressure seeds, acute pain, chronic pain

Brief summary

The purpose of this research study is to find out what effects (good and bad) acupressure applied to the outside of the ear (Auricular Acupressure), in addition to the standard of care medication regimen, will have on pain. This study is being done to assess whether acupressure in addition to prescribed pain medication may be of benefit in decreasing pain levels and improving overall wellbeing. This study will also evaluate the feasibility of routinely offering acupressure to patients having pain issues in addition to a psychiatric diagnosis.

Detailed description

The purpose of this study is to test the feasibility of Emergency Department nurse-initiated battlefield auricular acupressure as an adjunct to medication for pain management for psychiatric Emergency Department Observation patients. The Battlefield Auricula Acupressure interventionists (nurse) will complete Auricular training modules and complete competency assessments and intervention assessments throughout the study. Study interventionist will include the possibility that a study participant may be part of a competency assessment and that their session may be recorded and securely uploaded to a server per Institutional Review Board (IRB) and institutional policies.

Interventions

DEVICEAuricular Acupressure Pads

Pads containing seeds that are placed on specific sites of the ear that are thought to help with pain.

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients requiring admission to psychiatric emergency room who also have documented chronic or acute pain * History of chronic or acute pain with or without opioid use disorder * Expected length of stay at least 2-3 days at the time of recruitment * Able to read and understand the informed consent form

Exclusion criteria

* Since this is a feasibility pilot, only English-speaking participants will be eligible. * Cognitive impairment (Intellectual Disability Disorder or Dementia) * Patients who have a legal guardian * Participants with a history of skin disease (e.g., psoriasis) involving the ear, adhesive allergy, recent scar tissue on ear, or current abrasions or cuts on ear, * Use of some types of hearing aids (obstructing the placement of beads)

Design outcomes

Primary

MeasureTime frameDescription
Patient Reported Pain and General Activity Scores (Visual Analogue Scale)BaselineVisual Analogue Scale (VAS) for Pain is marked by subject on a line that ranges from 0mm to 100mm. The study team will measure where the participant marks to the nearest mm which will provide a score. Higher scores denote higher pain with higher levels of activity.
Pain Medication UsageDay 1Average milligram per day of a non-opioid analgesic.

Secondary

MeasureTime frameDescription
Battlefield Auricular Acupressure (BAA) Press Question 1 - Count of Participants Somewhat Satisfied or Satisfied.Day 3Number responding to the following question will be recorded: 1\. How satisfied were you with how your pain has been treated? using the Likert scale to measure Very satisfied =5, Satisfied=4, Somewhat satisfied = 3, Somewhat dissatisfied= 2, Dissatisfied 1, Very Dissatisfied 0. Range 0-5 with higher score indicating higher satisfaction.
Battlefield Auricular Acupressure (BAA) Press Question 2 - Count of Participants That Would Maybe Consider or Consider Intervention.Day 3Number responding to the following question will be recorded: Would you consider using auricular acupressure in the future for pain or if recommended by your nurse or physician? a. No, would not use again (Score of 0) b. Maybe (Score of 1), c. Yes, I would consider using in the future (Score of 2).
BAA Press Placement Survey (Interventionists Only) - Mean Time of Acupressure Seed PlacementDay 1The Interventionist (Acupressure nurse) will be asked to capture time related to completion of study tasks and other qualitative questions to assess overall feasibility. Time recorded in minutes.
General Anxiety Disorder Scale (GAD-7)BaselineGAD-7 is a 7 item scale to identify Generalized Anxiety Disorder symptoms of evaluation. Patients are asked to rate anxiety symptoms on a scale of 0-3. Total score ranges from 0-21. Higher scores indicate increased severity of anxiety. 7 item scale to identify Generalized Anxiety Disorder symptoms of evaluation. Patients are asked to rate anxiety symptoms on a scale of 0-3. Total score ranges from 0-21. Higher scores indicate increased severity of anxiety

Countries

United States

Participant flow

Participants by arm

ArmCount
Auricular Acupressure Pad Group
All subjects who qualify and agree to be in the study will be given Auricular Acupressure using an acupressure pad containing acupressure seeds for 4 days in addition to their regular standard of care pain medication. Auricular Acupressure Pads: Pads containing seeds that are placed on specific sites of the ear that are thought to help with pain.
11
Total11

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up1

Baseline characteristics

CharacteristicAuricular Acupressure Pad Group
Age, Continuous49.64 years
STANDARD_DEVIATION 14.88
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
5 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
3 Participants
Sex: Female, Male
Female
8 Participants
Sex: Female, Male
Male
3 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 11
other
Total, other adverse events
0 / 11
serious
Total, serious adverse events
0 / 11

Outcome results

Primary

Pain Medication Usage

Average milligram per day of a non-opioid analgesic.

Time frame: Day 1

ArmMeasureValue (MEAN)
Auricular Acupressure Pad GroupPain Medication Usage291 milligrams
Primary

Pain Medication Usage

Average milligram per day of a non-opioid analgesic.

Time frame: Day 2

ArmMeasureValue (MEAN)
Auricular Acupressure Pad GroupPain Medication Usage871 milligrams
Primary

Pain Medication Usage

Average milligram per day of a non-opioid analgesic.

Time frame: Day 3

ArmMeasureValue (MEAN)
Auricular Acupressure Pad GroupPain Medication Usage780 milligrams
Primary

Patient Reported Pain and General Activity Scores (Visual Analogue Scale)

Visual Analogue Scale (VAS) for Pain is marked by subject on a line that ranges from 0mm to 100mm. The study team will measure where the participant marks to the nearest mm which will provide a score. Higher scores denote higher pain with higher levels of activity.

Time frame: Day 3

ArmMeasureValue (MEAN)
Auricular Acupressure Pad GroupPatient Reported Pain and General Activity Scores (Visual Analogue Scale)42.2 mm
Primary

Patient Reported Pain and General Activity Scores (Visual Analogue Scale)

Visual Analogue Scale (VAS) for Pain is marked by subject on a line that ranges from 0mm to 100mm. The study team will measure where the participant marks to the nearest mm which will provide a score. Higher scores denote higher pain with higher levels of activity.

Time frame: Baseline

ArmMeasureValue (MEAN)
Auricular Acupressure Pad GroupPatient Reported Pain and General Activity Scores (Visual Analogue Scale)65 mm
Primary

Patient Reported Pain and General Activity Scores (Visual Analogue Scale)

Visual Analogue Scale (VAS) for Pain is marked by subject on a line that ranges from 0mm to 100mm. The study team will measure where the participant marks to the nearest mm which will provide a score. Higher scores denote higher pain with higher levels of activity.

Time frame: Day 1

ArmMeasureValue (MEAN)
Auricular Acupressure Pad GroupPatient Reported Pain and General Activity Scores (Visual Analogue Scale)57.3 mm
Primary

Patient Reported Pain and General Activity Scores (Visual Analogue Scale)

Visual Analogue Scale (VAS) for Pain is marked by subject on a line that ranges from 0mm to 100mm. The study team will measure where the participant marks to the nearest mm which will provide a score. Higher scores denote higher pain with higher levels of activity.

Time frame: Day 2

ArmMeasureValue (MEAN)
Auricular Acupressure Pad GroupPatient Reported Pain and General Activity Scores (Visual Analogue Scale)52.7 mm
Secondary

BAA Press Placement Survey (Interventionists Only) - Mean Time of Acupressure Seed Placement

The Interventionist (Acupressure nurse) will be asked to capture time related to completion of study tasks and other qualitative questions to assess overall feasibility. Time recorded in minutes.

Time frame: Day 1

ArmMeasureValue (MEAN)Dispersion
Auricular Acupressure Pad GroupBAA Press Placement Survey (Interventionists Only) - Mean Time of Acupressure Seed Placement11.5 minutesStandard Deviation 3.7
Secondary

Battlefield Auricular Acupressure (BAA) Press Question 1 - Count of Participants Somewhat Satisfied or Satisfied.

Number responding to the following question will be recorded: 1\. How satisfied were you with how your pain has been treated? using the Likert scale to measure Very satisfied =5, Satisfied=4, Somewhat satisfied = 3, Somewhat dissatisfied= 2, Dissatisfied 1, Very Dissatisfied 0. Range 0-5 with higher score indicating higher satisfaction.

Time frame: Day 3

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Auricular Acupressure Pad GroupBattlefield Auricular Acupressure (BAA) Press Question 1 - Count of Participants Somewhat Satisfied or Satisfied.Somewhat satisfied6 Participants
Auricular Acupressure Pad GroupBattlefield Auricular Acupressure (BAA) Press Question 1 - Count of Participants Somewhat Satisfied or Satisfied.Very dissatisfied0 Participants
Auricular Acupressure Pad GroupBattlefield Auricular Acupressure (BAA) Press Question 1 - Count of Participants Somewhat Satisfied or Satisfied.Dissatisfied0 Participants
Auricular Acupressure Pad GroupBattlefield Auricular Acupressure (BAA) Press Question 1 - Count of Participants Somewhat Satisfied or Satisfied.Somewhat dissatisfied0 Participants
Auricular Acupressure Pad GroupBattlefield Auricular Acupressure (BAA) Press Question 1 - Count of Participants Somewhat Satisfied or Satisfied.Satisfied4 Participants
Auricular Acupressure Pad GroupBattlefield Auricular Acupressure (BAA) Press Question 1 - Count of Participants Somewhat Satisfied or Satisfied.Very satisfied0 Participants
Secondary

Battlefield Auricular Acupressure (BAA) Press Question 2 - Count of Participants That Would Maybe Consider or Consider Intervention.

Number responding to the following question will be recorded: Would you consider using auricular acupressure in the future for pain or if recommended by your nurse or physician? a. No, would not use again (Score of 0) b. Maybe (Score of 1), c. Yes, I would consider using in the future (Score of 2).

Time frame: Day 3

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Auricular Acupressure Pad GroupBattlefield Auricular Acupressure (BAA) Press Question 2 - Count of Participants That Would Maybe Consider or Consider Intervention.Yes, I would consider using in the future8 Participants
Auricular Acupressure Pad GroupBattlefield Auricular Acupressure (BAA) Press Question 2 - Count of Participants That Would Maybe Consider or Consider Intervention.Maybe2 Participants
Auricular Acupressure Pad GroupBattlefield Auricular Acupressure (BAA) Press Question 2 - Count of Participants That Would Maybe Consider or Consider Intervention.No, would not use again0 Participants
Secondary

General Anxiety Disorder Scale (GAD-7)

GAD-7 is a 7 item scale to identify Generalized Anxiety Disorder symptoms of evaluation. Patients are asked to rate anxiety symptoms on a scale of 0-3. Total score ranges from 0-21. Higher scores indicate increased severity of anxiety. 7 item scale to identify Generalized Anxiety Disorder symptoms of evaluation. Patients are asked to rate anxiety symptoms on a scale of 0-3. Total score ranges from 0-21. Higher scores indicate increased severity of anxiety

Time frame: Baseline

ArmMeasureValue (MEAN)
Auricular Acupressure Pad GroupGeneral Anxiety Disorder Scale (GAD-7)15.0 score on a scale
Secondary

General Anxiety Disorder Scale (GAD-7)

GAD-7 is a 7 item scale to identify Generalized Anxiety Disorder symptoms of evaluation. Patients are asked to rate anxiety symptoms on a scale of 0-3. Total score ranges from 0-21. Higher scores indicate increased severity of anxiety. 7 item scale to identify Generalized Anxiety Disorder symptoms of evaluation. Patients are asked to rate anxiety symptoms on a scale of 0-3. Total score ranges from 0-21. Higher scores indicate increased severity of anxiety

Time frame: Day 1

ArmMeasureValue (MEAN)
Auricular Acupressure Pad GroupGeneral Anxiety Disorder Scale (GAD-7)9.7 score on a scale
Secondary

General Anxiety Disorder Scale (GAD-7)

GAD-7 is a 7 item scale to identify Generalized Anxiety Disorder symptoms of evaluation. Patients are asked to rate anxiety symptoms on a scale of 0-3. Total score ranges from 0-21. Higher scores indicate increased severity of anxiety. 7 item scale to identify Generalized Anxiety Disorder symptoms of evaluation. Patients are asked to rate anxiety symptoms on a scale of 0-3. Total score ranges from 0-21. Higher scores indicate increased severity of anxiety

Time frame: Day 2

ArmMeasureValue (MEAN)
Auricular Acupressure Pad GroupGeneral Anxiety Disorder Scale (GAD-7)7.1 score on a scale
Secondary

General Anxiety Disorder Scale (GAD-7)

GAD-7 is a 7 item scale to identify Generalized Anxiety Disorder symptoms of evaluation. Patients are asked to rate anxiety symptoms on a scale of 0-3. Total score ranges from 0-21. Higher scores indicate increased severity of anxiety. 7 item scale to identify Generalized Anxiety Disorder symptoms of evaluation. Patients are asked to rate anxiety symptoms on a scale of 0-3. Total score ranges from 0-21. Higher scores indicate increased severity of anxiety

Time frame: Day 3

ArmMeasureValue (MEAN)
Auricular Acupressure Pad GroupGeneral Anxiety Disorder Scale (GAD-7)5.7 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026